Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
4D Pharma
4D Pharma
(LBPS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ziv-aflibercept
macular edema
,
edema
,
macular degeneration
,
wet macular degeneration
,
retinal vein occlusion
Ademetionine
neoplasms
,
aggressive fibromatosis
,
glioma
Microcrystalline cellulose
atrophy
,
postmenopause
Mk3475
neoplasms
,
urologic neoplasms
,
carcinoma
,
breast neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
squamous cell carcinoma of head and neck
,
transitional cell carcinoma
,
squamous cell carcinoma
MRX0518
pancreatic neoplasms
,
prostatic neoplasms
,
breast neoplasms
,
ovarian neoplasms
,
head and neck neoplasms
,
lung neoplasms
,
uterine neoplasms
,
kidney neoplasms
,
urethral neoplasms
,
urinary bladder neoplasms
,
melanoma
,
renal cell carcinoma
,
neoplasms
,
non-small-cell lung carcinoma
,
oncogenes
,
urologic neoplasms
,
carcinoma
,
transitional cell carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use